The global diabetes market is experiencing rapid growth driven by the increasing prevalence of this chronic disease. At the forefront of this evolution are leading developers of GLP-1 receptor agonists, a class of https://my-social-box.com/story5808167/leading-glp-1-manufacturers-innovation-in-diabetes-treatment